Stay updated on Aldesleukin and Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Aldesleukin and Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Aldesleukin and Pembrolizumab in Melanoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision metadata updated to v3.6.5, indicating a backend/software update; no observable changes to the study details.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page's footer revision label changed from v3.6.3 to v3.6.4, indicating a new deployment version of the page. No study content or data was modified.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page's footer revision label was updated from v3.6.2 to v3.6.3, indicating a small software update rather than changes to study information.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous v3.6.0. This indicates a maintenance/template update rather than a change to the study details or visible content.SummaryDifference0.0%

- Check72 days agoChange DetectedThe study page now displays a 'No longer looking for participants' notice indicating recruitment has closed and adds new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment header formatting was updated and the revision label changed from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check79 days agoChange DetectedFooter revision tag updated from v3.5.4 to v3.5.5, signaling a minor maintenance release. No user-facing content or study data are affected.SummaryDifference0.0%

Stay in the know with updates to Aldesleukin and Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Aldesleukin and Pembrolizumab in Melanoma Clinical Trial page.